A Clinical Trial to Evaluate Safety, Tolerability and Pharmacokinetic/Pharmacodynamic Characteristics of KMRC011

Clinical trial NCT03585803 · COMPLETED

Trial details

NCT number: NCT03585803
Sponsor: Intron Biotechnology, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Acute Radiation Syndrome

Start date: 2018-06-11
Primary completion: 2019-09-11
Enrollment: 26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.